The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (100.37) USD. With the latest stock price at 5.75 USD, the upside of FibroGen Inc based on DCF is -1845.6%.
Based on the latest price of 5.75 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 1845.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 19.0% | 12.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (909.05) - (60.78) | (100.37) |
| Upside | -15909.5% - -1157.0% | -1845.6% |